mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains

نویسندگان

  • Kelly P. Smith
  • Meg Byron
  • Carol Johnson
  • Yigong Xing
چکیده

Nuclear mRNA transport is often thought of in terms of translocation through the nuclear pore, but mRNA export also requires intranuclear progression of transcripts from the gene to the nuclear pore. In some genetic diseases, failed export of a mutant mRNA is critical to the phenotype, yet typically it is not well understood how nuclear export is impeded or whether mutant mRNA accumulates at a specifi c point within the nuclear structure. In fact, the examination of mRNA blocked at a specifi c step in export may help illuminate the path whereby mRNA normally transits from the gene to the nuclear pore. The analysis of human disease gene mutations that impact nuclear metabolism of the mRNA provides an avenue to study both disease pathogenesis and the interrelationship between nuclear structure and steps in mRNA biogenesis. In addition, the study of naturally occurring disease alleles in patient cells provides the advantage that the mutant mRNA is expressed in a normal structural and physiological context. This study examines the intranuclear fate of normal and triplet repeat–expanded transcripts in myotonic dystrophy type 1 (DM1) to defi ne the point in the nuclear structure where the progression of normal and mutant transcripts diverge, which, in turn, provides insight into the step at which mutant mRNA transport is blocked. In DM1, expansion of a CTG triplet repeat occurs in the 3′ untranslated region of the gene encoding dystrophia myotonica protein kinase (DMPK), a serine/threonine protein kinase (Aslanidis et al., 1992; Brook et al., 1992; Fu et al., 1992; Mahadevan et al., 1992). Normal alleles have 5–35 repeats, whereas DM1 alleles have 50 to >1,000. It has been shown that the mutant DMPK genes encode mRNAs containing expanded repeat sequences and that these RNAs are sequestered in the nucleus, where they accumulate in discrete nuclear foci (Taneja et al., 1995; Hamshere et al., 1997; Liquori et al., 2001). However, it is not known whether normal DMPK mRNA associates with any defi ned intranuclear nuclear structure after its transcription and whether this differs for the mutant RNA. In addition to the defect in mRNA transport in DM1, it is hypothesized that the expanded repeat RNAs alter the nuclear distri bution or activity of specifi c CUG-binding proteins, which, in turn, affects the alternative splicing of other pre-mRNAs (Day and Ranum, 2005; Osborne and Thornton, 2006). Multiple proteins such as CUG-binding protein (Timchenko et al., 1996, 2001; Philips et al., 1998), heterogeneous nuclear RNP H (hnRNP H; Kim et al., 2005), double-stranded RNA–binding proteins Defi ning early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains

In myotonic dystrophy type 1 (DM1), triplet repeat expansion in the 3' untranslated region of dystrophia myotonica protein kinase (DMPK) causes the nuclear retention of mutant messenger RNA (mRNA). Although the DMPK gene locus positions precisely at the outer edge of a factor-rich SC-35 domain, the normal mRNA consistently accumulates within the domain, and this RNA is depleted upon transcripti...

متن کامل

Genotype–Phenotype Correlations in Iranian Myotonic Dystrophy Type I Patients

Objectives: Myotonic Dystrophy type I (DM1) is a dominantly inherited disorder with a multisystemic pattern affecting skeletal muscle, heart, eye, endocrine and central nervous system. DM1 is associated with the expansion and instability of CTG repeat in the 3chr('39') untranslated region of the myotonic dystrophy protein kinase (DMPK) gene located on chromosome 19q13.3. The aim of this study w...

متن کامل

The myotonic dystrophy type 2 protein ZNF9 is part of an ITAF complex that promotes cap-independent translation.

The 5'-untranslated region of the ornithine decarboxylase (ODC) mRNA contains an internal ribosomal entry site (IRES). Mutational analysis of the ODC IRES has led to the identification of sequences necessary for cap-independent translation of the ODC mRNA. To discover novel IRES trans-acting factors (ITAFs), we performed a proteomics screen for proteins that regulate ODC translation using the w...

متن کامل

ZNF9 Activation of IRES-Mediated Translation of the Human ODC mRNA Is Decreased in Myotonic Dystrophy Type 2

Myotonic dystrophy types 1 and 2 (DM1 and DM2) are forms of muscular dystrophy that share similar clinical and molecular manifestations, such as myotonia, muscle weakness, cardiac anomalies, cataracts, and the presence of defined RNA-containing foci in muscle nuclei. DM2 is caused by an expansion of the tetranucleotide CCTG repeat within the first intron of ZNF9, although the mechanism by which...

متن کامل

Myotonic Dystrophy is an autosomally dominant inherited disease affecting individuals of all ages

Myotonic Dystrophy is an autosomally dominant inherited disease affecting individuals of all ages. It’s prevalence among Caucasians is estimated at 35 per 100,000 individuals in the population. (1) The age of onset allows for specific classification of the disease into one of four categories: congenital, which appears at birth; juvenile, appearing up through teenage years; adult, symptoms start...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2007